Share Price and Basic Stock Data
Last Updated: October 18, 2025, 5:01 pm
| PEG Ratio | 2.80 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Emkay Global Financial Services Ltd operates in the finance and investments sector, demonstrating a fluctuating revenue trajectory over recent quarters. In the fiscal year ending March 2023, the company recorded sales of ₹215 Cr, a decline from ₹272 Cr in the previous year. However, sales showed signs of recovery in subsequent quarters, with ₹70.54 Cr in September 2023 and ₹75.20 Cr in December 2023. The latest figures from March 2024 indicate a more robust performance with sales rising to ₹90.98 Cr. This upward trend continued into the following quarters, hinting at a potential rebound. Despite the historical challenges, the company’s sales figures for the upcoming fiscal year 2025 are set to climb to ₹360 Cr, reflecting a strategic recovery and growth initiative. The operating profit margins have been volatile, with an operating profit margin (OPM) of 7.99% at the end of the latest reporting period. This figure, while lower than the industry average, indicates improving operational efficiency as the company navigates through its financial landscape.
Profitability and Efficiency Metrics
Emkay Global’s profitability metrics reveal a complex picture marked by volatility. The net profit for the trailing twelve months stood at ₹57 Cr, translating to an earnings per share (EPS) of ₹22.40 for the fiscal year ending March 2025. This represents a significant rebound from the negative net profit of ₹5.37 Cr recorded in March 2023. The return on equity (ROE) is reported at 20.9%, while the return on capital employed (ROCE) stands at 20.4%, both indicating effective utilization of equity and capital. However, the interest coverage ratio (ICR) is notably high at 11.64x, indicating that the company is well-positioned to meet its interest obligations. The cash conversion cycle (CCC) has been reduced to 95 days, showcasing an improvement in operational efficiency, although the figure remains elevated compared to industry benchmarks. Overall, while profitability is on an upward trajectory, operational challenges remain evident, necessitating continued focus on cost management and revenue enhancement strategies.
Balance Sheet Strength and Financial Ratios
Emkay Global’s balance sheet reflects a resilient financial framework, with total assets reported at ₹1,233 Cr against total liabilities of ₹1,065 Cr. The company’s reserves have strengthened significantly, rising to ₹278 Cr, while borrowings are relatively low at ₹68 Cr, resulting in a debt-to-equity ratio of 0.17. This low leverage indicates a prudent capital structure, enabling the company to weather market fluctuations. The book value per share has also improved to ₹97.54, further enhancing shareholder value. The current and quick ratios, both at 1.31, suggest that the company maintains adequate liquidity to cover short-term obligations. On the profitability front, the operating profit margin (OPM) for the latest fiscal year is 22%, which is an improvement from the 12% reported in the previous year. However, the company must continue to manage its operational costs effectively to sustain these margins and enhance profitability in a competitive financial services landscape.
Shareholding Pattern and Investor Confidence
Emkay Global’s shareholding pattern indicates a strong promoter commitment, with promoters holding 72.03% of the company’s equity. This significant stake reflects confidence in the company’s long-term strategy. Foreign institutional investors (FIIs) have a minimal stake of 0.85%, while domestic institutional investors (DIIs) hold just 0.01%. The public shareholding has increased to 27.11%, suggesting a growing interest among retail investors. The total number of shareholders has seen a decline, now standing at 11,436, which may indicate consolidation among investors. The consistent promoter shareholding, despite slight reductions, suggests a strategic approach to maintaining control while potentially inviting more public investment. This pattern can foster greater investor confidence, though the low institutional participation could raise concerns about the company’s visibility and attractiveness in the broader market.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies continue to improve, Emkay Global could capitalize on its market position to enhance profitability further. However, risks remain, including potential fluctuations in market conditions and regulatory changes that could impact revenue generation. The company’s reliance on a narrow base of institutional investors may limit its capital-raising capabilities, and any downturn in investor sentiment could adversely affect its share price. Additionally, maintaining a balance between growth and cost management will be crucial for sustaining profitability. If the company successfully navigates these challenges while leveraging its strong balance sheet and promoter backing, it could emerge as a more formidable player in the financial services sector, paving the way for sustained growth and improved shareholder returns.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Emkay Global Financial Services Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Shares & Stockbrokers Ltd | 12.1 Cr. | 41.3 | 67.7/36.4 | 43.2 | 43.5 | 0.00 % | 3.32 % | 1.74 % | 10.0 |
| Monarch Networth Capital Ltd | 2,445 Cr. | 308 | 495/280 | 15.8 | 102 | 0.32 % | 33.3 % | 26.2 % | 10.0 |
| Monotype India Ltd | 37.3 Cr. | 0.53 | 2.42/0.46 | 3.62 | 0.02 | 0.00 % | 286 % | % | 1.00 |
| Multipurpose Trading & Agencies Ltd | 4.49 Cr. | 9.08 | 12.7/8.25 | 10.3 | 0.00 % | 3.68 % | 3.38 % | 10.0 | |
| Munoth Financial Services Ltd | 24.4 Cr. | 47.6 | 72.0/47.6 | 20.6 | 0.00 % | 2.41 % | 3.38 % | 10.0 | |
| Industry Average | 6,763.07 Cr | 1,429.69 | 132.51 | 3,769.18 | 0.31% | 21.70% | 14.20% | 7.28 |
All Competitor Stocks of Emkay Global Financial Services Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 51.97 | 56.62 | 54.32 | 42.15 | 46.65 | 70.54 | 75.20 | 90.98 | 82.69 | 108.02 | 77.30 | 71.04 | 72.97 |
| Expenses | 43.22 | 46.98 | 47.91 | 53.99 | 52.21 | 62.98 | 64.70 | 78.10 | 67.61 | 78.93 | 67.87 | 70.93 | 67.14 |
| Operating Profit | 8.75 | 9.64 | 6.41 | -11.84 | -5.56 | 7.56 | 10.50 | 12.88 | 15.08 | 29.09 | 9.43 | 0.11 | 5.83 |
| OPM % | 16.84% | 17.03% | 11.80% | -28.09% | -11.92% | 10.72% | 13.96% | 14.16% | 18.24% | 26.93% | 12.20% | 0.15% | 7.99% |
| Other Income | 1.41 | 1.34 | 1.94 | 8.30 | 9.13 | 7.52 | 8.19 | 8.44 | 6.43 | 6.78 | 6.58 | 5.81 | 4.78 |
| Interest | 0.78 | 0.91 | 1.25 | 1.34 | 0.83 | 1.12 | 1.29 | 1.66 | 1.78 | 1.65 | 1.84 | 1.68 | 2.44 |
| Depreciation | 2.02 | 2.28 | 2.44 | 2.44 | 1.98 | 2.08 | 2.68 | 3.06 | 2.62 | 2.79 | 2.94 | 3.29 | 2.91 |
| Profit before tax | 7.36 | 7.79 | 4.66 | -7.32 | 0.76 | 11.88 | 14.72 | 16.60 | 17.11 | 31.43 | 11.23 | 0.95 | 5.26 |
| Tax % | 40.35% | 19.64% | -84.55% | -27.46% | 119.74% | 18.94% | 16.51% | 37.35% | 18.47% | 17.88% | 22.26% | -786.32% | 8.75% |
| Net Profit | 4.58 | 6.12 | 8.74 | -5.37 | 0.34 | 9.27 | 12.26 | 10.56 | 13.87 | 25.91 | 8.57 | 8.49 | 4.78 |
| EPS in Rs | 1.86 | 2.48 | 3.55 | -2.18 | 0.14 | 3.76 | 4.97 | 4.28 | 5.61 | 10.43 | 3.43 | 3.35 | 1.88 |
Last Updated: August 20, 2025, 11:10 am
Below is a detailed analysis of the quarterly data for Emkay Global Financial Services Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 72.97 Cr.. The value appears strong and on an upward trend. It has increased from 71.04 Cr. (Mar 2025) to 72.97 Cr., marking an increase of 1.93 Cr..
- For Expenses, as of Jun 2025, the value is 67.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 70.93 Cr. (Mar 2025) to 67.14 Cr., marking a decrease of 3.79 Cr..
- For Operating Profit, as of Jun 2025, the value is 5.83 Cr.. The value appears strong and on an upward trend. It has increased from 0.11 Cr. (Mar 2025) to 5.83 Cr., marking an increase of 5.72 Cr..
- For OPM %, as of Jun 2025, the value is 7.99%. The value appears strong and on an upward trend. It has increased from 0.15% (Mar 2025) to 7.99%, marking an increase of 7.84%.
- For Other Income, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 5.81 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 2.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.68 Cr. (Mar 2025) to 2.44 Cr., marking an increase of 0.76 Cr..
- For Depreciation, as of Jun 2025, the value is 2.91 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.29 Cr. (Mar 2025) to 2.91 Cr., marking a decrease of 0.38 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.26 Cr.. The value appears strong and on an upward trend. It has increased from 0.95 Cr. (Mar 2025) to 5.26 Cr., marking an increase of 4.31 Cr..
- For Tax %, as of Jun 2025, the value is 8.75%. The value appears to be increasing, which may not be favorable. It has increased from -786.32% (Mar 2025) to 8.75%, marking an increase of 795.07%.
- For Net Profit, as of Jun 2025, the value is 4.78 Cr.. The value appears to be declining and may need further review. It has decreased from 8.49 Cr. (Mar 2025) to 4.78 Cr., marking a decrease of 3.71 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.88. The value appears to be declining and may need further review. It has decreased from 3.35 (Mar 2025) to 1.88, marking a decrease of 1.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:24 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 82 | 117 | 105 | 109 | 156 | 147 | 135 | 160 | 272 | 215 | 314 | 360 | 329 |
| Expenses | 76 | 82 | 82 | 85 | 111 | 124 | 137 | 134 | 217 | 189 | 258 | 282 | 285 |
| Operating Profit | 6 | 34 | 24 | 24 | 45 | 23 | -3 | 26 | 55 | 25 | 56 | 79 | 44 |
| OPM % | 8% | 29% | 22% | 22% | 29% | 15% | -2% | 16% | 20% | 12% | 18% | 22% | 14% |
| Other Income | 1 | -36 | 0 | 0 | 0 | 3 | 0 | 2 | 1 | 1 | 2 | 1 | 24 |
| Interest | 5 | 5 | 4 | 3 | 4 | 7 | 7 | 3 | 3 | 4 | 5 | 7 | 8 |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 7 | 8 | 8 | 8 | 9 | 10 | 12 | 12 |
| Profit before tax | -3 | -11 | 17 | 16 | 37 | 12 | -17 | 17 | 46 | 12 | 44 | 61 | 49 |
| Tax % | 40% | 49% | 28% | 26% | 22% | 31% | -29% | 32% | 24% | -12% | 27% | 6% | |
| Net Profit | -4 | -16 | 12 | 12 | 29 | 9 | -13 | 11 | 34 | 14 | 32 | 57 | 48 |
| EPS in Rs | -1.62 | -6.44 | 4.92 | 4.99 | 11.66 | 3.55 | -5.11 | 4.52 | 13.72 | 5.71 | 13.14 | 22.40 | 19.09 |
| Dividend Payout % | 0% | 0% | 20% | 20% | 17% | 28% | 0% | 22% | 9% | 18% | 11% | 18% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -300.00% | 175.00% | 0.00% | 141.67% | -68.97% | -244.44% | 184.62% | 209.09% | -58.82% | 128.57% | 78.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 475.00% | -175.00% | 141.67% | -210.63% | -175.48% | 429.06% | 24.48% | -267.91% | 187.39% | -50.45% |
Emkay Global Financial Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 22% |
| 3 Years: | 10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 46% |
| 3 Years: | 19% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 31% |
| 3 Years: | 36% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 14% |
| 3 Years: | 14% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:30 am
Balance Sheet
Last Updated: July 25, 2025, 3:17 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 105 | 89 | 98 | 111 | 137 | 142 | 128 | 142 | 176 | 186 | 216 | 278 |
| Borrowings | 34 | 35 | 11 | 49 | 34 | 23 | 10 | 17 | 44 | 33 | 52 | 68 |
| Other Liabilities | 110 | 112 | 92 | 116 | 169 | 136 | 218 | 381 | 519 | 488 | 772 | 862 |
| Total Liabilities | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 |
| Fixed Assets | 39 | 36 | 35 | 35 | 33 | 35 | 38 | 34 | 32 | 38 | 43 | 41 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Investments | 3 | 4 | 11 | 26 | 36 | 28 | 16 | 29 | 34 | 24 | 26 | 32 |
| Other Assets | 232 | 221 | 180 | 237 | 296 | 263 | 327 | 501 | 696 | 669 | 996 | 1,160 |
| Total Assets | 274 | 261 | 226 | 299 | 365 | 326 | 381 | 565 | 764 | 731 | 1,065 | 1,233 |
Below is a detailed analysis of the balance sheet data for Emkay Global Financial Services Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
- For Reserves, as of Mar 2025, the value is 278.00 Cr.. The value appears strong and on an upward trend. It has increased from 216.00 Cr. (Mar 2024) to 278.00 Cr., marking an increase of 62.00 Cr..
- For Borrowings, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 52.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 16.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 862.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 772.00 Cr. (Mar 2024) to 862.00 Cr., marking an increase of 90.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,233.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,065.00 Cr. (Mar 2024) to 1,233.00 Cr., marking an increase of 168.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2024) to 41.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 32.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2024) to 32.00 Cr., marking an increase of 6.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,160.00 Cr.. The value appears strong and on an upward trend. It has increased from 996.00 Cr. (Mar 2024) to 1,160.00 Cr., marking an increase of 164.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,233.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,065.00 Cr. (Mar 2024) to 1,233.00 Cr., marking an increase of 168.00 Cr..
Notably, the Reserves (278.00 Cr.) exceed the Borrowings (68.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -28.00 | -1.00 | 13.00 | -25.00 | 11.00 | 0.00 | -13.00 | 9.00 | 11.00 | -8.00 | 4.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 173 | 169 | 66 | 218 | 208 | 146 | 145 | 152 | 119 | 179 | 145 | 95 |
| Working Capital Days | -6 | -59 | -161 | -172 | -150 | -134 | -353 | -564 | -372 | -380 | -463 | -271 |
| ROCE % | 2% | 19% | 14% | 12% | 22% | 9% | -6% | 12% | 23% | 7% | 17% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.80 | 13.16 | 5.71 | 13.72 | 4.52 |
| Diluted EPS (Rs.) | 21.95 | 12.74 | 5.68 | 12.97 | 4.52 |
| Cash EPS (Rs.) | 27.02 | 17.00 | 9.39 | 17.22 | 7.90 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 119.51 | 97.54 | 85.38 | 81.42 | 67.59 |
| Revenue From Operations / Share (Rs.) | 132.52 | 114.39 | 82.39 | 110.07 | 66.00 |
| PBDIT / Share (Rs.) | 31.27 | 23.13 | 10.55 | 23.07 | 12.30 |
| PBIT / Share (Rs.) | 26.68 | 19.16 | 6.83 | 20.00 | 9.20 |
| PBT / Share (Rs.) | 23.94 | 17.18 | 5.09 | 18.72 | 7.05 |
| Net Profit / Share (Rs.) | 22.44 | 13.03 | 5.66 | 14.15 | 4.80 |
| NP After MI And SOA / Share (Rs.) | 22.40 | 13.14 | 5.71 | 13.72 | 4.52 |
| PBDIT Margin (%) | 23.59 | 20.22 | 12.81 | 20.96 | 18.63 |
| PBIT Margin (%) | 20.13 | 16.75 | 8.28 | 18.16 | 13.94 |
| PBT Margin (%) | 18.06 | 15.01 | 6.17 | 17.00 | 10.68 |
| Net Profit Margin (%) | 16.93 | 11.39 | 6.87 | 12.85 | 7.28 |
| NP After MI And SOA Margin (%) | 16.90 | 11.48 | 6.93 | 12.46 | 6.85 |
| Return on Networth / Equity (%) | 18.74 | 13.46 | 6.69 | 16.84 | 6.69 |
| Return on Capital Employeed (%) | 16.67 | 15.98 | 6.82 | 18.20 | 11.91 |
| Return On Assets (%) | 4.60 | 3.04 | 1.92 | 4.42 | 1.97 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.14 | 0.01 |
| Total Debt / Equity (X) | 0.19 | 0.17 | 0.12 | 0.19 | 0.07 |
| Asset Turnover Ratio (%) | 0.29 | 0.31 | 0.26 | 0.27 | 0.31 |
| Current Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Quick Ratio (X) | 1.41 | 1.31 | 1.38 | 1.46 | 1.38 |
| Dividend Payout Ratio (NP) (%) | 6.54 | 7.59 | 21.88 | 7.28 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 5.43 | 5.83 | 13.24 | 5.94 | 0.00 |
| Earning Retention Ratio (%) | 93.46 | 92.41 | 78.12 | 92.72 | 0.00 |
| Cash Earning Retention Ratio (%) | 94.57 | 94.17 | 86.76 | 94.06 | 0.00 |
| Interest Coverage Ratio (X) | 11.40 | 11.64 | 6.08 | 18.01 | 5.73 |
| Interest Coverage Ratio (Post Tax) (X) | 9.18 | 7.24 | 4.27 | 12.06 | 3.24 |
| Enterprise Value (Cr.) | 58.78 | -251.00 | -164.08 | -116.33 | -163.84 |
| EV / Net Operating Revenue (X) | 0.17 | -0.88 | -0.80 | -0.42 | -1.01 |
| EV / EBITDA (X) | 0.74 | -4.39 | -6.31 | -2.05 | -5.41 |
| MarketCap / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| Retention Ratios (%) | 93.45 | 92.40 | 78.11 | 92.71 | 0.00 |
| Price / BV (X) | 1.78 | 1.20 | 0.75 | 1.28 | 0.96 |
| Price / Net Operating Revenue (X) | 1.60 | 1.02 | 0.78 | 0.94 | 0.98 |
| EarningsYield | 0.10 | 0.11 | 0.08 | 0.13 | 0.06 |
After reviewing the key financial ratios for Emkay Global Financial Services Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 22.80. This value is within the healthy range. It has increased from 13.16 (Mar 24) to 22.80, marking an increase of 9.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 21.95. This value is within the healthy range. It has increased from 12.74 (Mar 24) to 21.95, marking an increase of 9.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 27.02. This value is within the healthy range. It has increased from 17.00 (Mar 24) to 27.02, marking an increase of 10.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 119.51. It has increased from 97.54 (Mar 24) to 119.51, marking an increase of 21.97.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 132.52. It has increased from 114.39 (Mar 24) to 132.52, marking an increase of 18.13.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.27. This value is within the healthy range. It has increased from 23.13 (Mar 24) to 31.27, marking an increase of 8.14.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.68. This value is within the healthy range. It has increased from 19.16 (Mar 24) to 26.68, marking an increase of 7.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 23.94. This value is within the healthy range. It has increased from 17.18 (Mar 24) to 23.94, marking an increase of 6.76.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 22.44. This value is within the healthy range. It has increased from 13.03 (Mar 24) to 22.44, marking an increase of 9.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 22.40. This value is within the healthy range. It has increased from 13.14 (Mar 24) to 22.40, marking an increase of 9.26.
- For PBDIT Margin (%), as of Mar 25, the value is 23.59. This value is within the healthy range. It has increased from 20.22 (Mar 24) to 23.59, marking an increase of 3.37.
- For PBIT Margin (%), as of Mar 25, the value is 20.13. This value exceeds the healthy maximum of 20. It has increased from 16.75 (Mar 24) to 20.13, marking an increase of 3.38.
- For PBT Margin (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 18.06, marking an increase of 3.05.
- For Net Profit Margin (%), as of Mar 25, the value is 16.93. This value exceeds the healthy maximum of 10. It has increased from 11.39 (Mar 24) to 16.93, marking an increase of 5.54.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 16.90. This value is within the healthy range. It has increased from 11.48 (Mar 24) to 16.90, marking an increase of 5.42.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.74. This value is within the healthy range. It has increased from 13.46 (Mar 24) to 18.74, marking an increase of 5.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.67. This value is within the healthy range. It has increased from 15.98 (Mar 24) to 16.67, marking an increase of 0.69.
- For Return On Assets (%), as of Mar 25, the value is 4.60. This value is below the healthy minimum of 5. It has increased from 3.04 (Mar 24) to 4.60, marking an increase of 1.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.19, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has decreased from 0.31 (Mar 24) to 0.29, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has increased from 1.31 (Mar 24) to 1.41, marking an increase of 0.10.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.54. This value is below the healthy minimum of 20. It has decreased from 7.59 (Mar 24) to 6.54, marking a decrease of 1.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.43. This value is below the healthy minimum of 20. It has decreased from 5.83 (Mar 24) to 5.43, marking a decrease of 0.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.46. This value exceeds the healthy maximum of 70. It has increased from 92.41 (Mar 24) to 93.46, marking an increase of 1.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.57. This value exceeds the healthy maximum of 70. It has increased from 94.17 (Mar 24) to 94.57, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 11.40. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 11.40, marking a decrease of 0.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.18. This value is within the healthy range. It has increased from 7.24 (Mar 24) to 9.18, marking an increase of 1.94.
- For Enterprise Value (Cr.), as of Mar 25, the value is 58.78. It has increased from -251.00 (Mar 24) to 58.78, marking an increase of 309.78.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 1. It has increased from -0.88 (Mar 24) to 0.17, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from -4.39 (Mar 24) to 0.74, marking an increase of 5.13.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For Retention Ratios (%), as of Mar 25, the value is 93.45. This value exceeds the healthy maximum of 70. It has increased from 92.40 (Mar 24) to 93.45, marking an increase of 1.05.
- For Price / BV (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has increased from 1.20 (Mar 24) to 1.78, marking an increase of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has increased from 1.02 (Mar 24) to 1.60, marking an increase of 0.58.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.10, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emkay Global Financial Services Ltd:
- Net Profit Margin: 16.93%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.67% (Industry Average ROCE: 21.7%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.74% (Industry Average ROE: 14.2%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.18
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.41
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 19.1 (Industry average Stock P/E: 132.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 16.93%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Finance & Investments | The Ruby, 7th Floor, Mumbai Maharashtra 400028 | secretarial@emkayglobal.com http://www.emkayglobal.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. S K Saboo | Chairman |
| Mr. Krishna Kumar Karwa | Managing Director |
| Mr. Prakash Kacholia | Managing Director |
| Mr. Raunak Karwa | Non Executive Director |
| Dr. Bharat Kumar Singh | Independent Director |
| Dr. Satish Ugrankar | Independent Director |
| Mr. A Dhananjaya | Independent Director |
| Mrs. Hutokshi Wadia | Independent Woman Director |
FAQ
What is the intrinsic value of Emkay Global Financial Services Ltd?
Emkay Global Financial Services Ltd's intrinsic value (as of 19 October 2025) is 384.83 which is 8.10% higher the current market price of 356.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 912 Cr. market cap, FY2025-2026 high/low of 410/162, reserves of ₹278 Cr, and liabilities of 1,233 Cr.
What is the Market Cap of Emkay Global Financial Services Ltd?
The Market Cap of Emkay Global Financial Services Ltd is 912 Cr..
What is the current Stock Price of Emkay Global Financial Services Ltd as on 19 October 2025?
The current stock price of Emkay Global Financial Services Ltd as on 19 October 2025 is 356.
What is the High / Low of Emkay Global Financial Services Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Emkay Global Financial Services Ltd stocks is 410/162.
What is the Stock P/E of Emkay Global Financial Services Ltd?
The Stock P/E of Emkay Global Financial Services Ltd is 19.1.
What is the Book Value of Emkay Global Financial Services Ltd?
The Book Value of Emkay Global Financial Services Ltd is 120.
What is the Dividend Yield of Emkay Global Financial Services Ltd?
The Dividend Yield of Emkay Global Financial Services Ltd is 0.42 %.
What is the ROCE of Emkay Global Financial Services Ltd?
The ROCE of Emkay Global Financial Services Ltd is 20.4 %.
What is the ROE of Emkay Global Financial Services Ltd?
The ROE of Emkay Global Financial Services Ltd is 20.9 %.
What is the Face Value of Emkay Global Financial Services Ltd?
The Face Value of Emkay Global Financial Services Ltd is 10.0.